VPC-12249

N/A

Report date: 2021/12/07 16:28:47
NME

Base Information

Drug NameVPC-12249
Drug Alias NameVPC12249
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLysophosphatidic acid receptor Edg-2 antagonistsLysophosphatidic acid receptor Edg-7 antagonists
TargetsLysophosphatidic acid receptor Edg-2Lysophosphatidic acid receptor Edg-7
Therapy Area/IndicationsPulmonary Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesUniversity Of Virginia
China Registration ClassN/A

Develop Information

Active CompaniesWest China Hospital Of Sichuan University
Inactive CompaniesN/A
Active IndicationsPulmonary Fibrosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A